Table Of Contents

1. Introduction 17
1.1. Objectives Of The Study 17
1.2. Market Definition 17
1.3. Overview Of Asia-Pacific Point-Of-Care Testing Market 18
1.4. Currency And Pricing 19
1.5. Limitation 19
1.6. Markets Covered 20
2. Market Segmentation 22
2.1. Markets Covered 22
2.2. Geographic Scope 23
2.3. Years Considered For The Study 24
2.4. Currency And Pricing 24
2.5. Research Methodology 25
2.6. Primary Interviews With Key Opinion Leaders 29
2.7. Secondary Source 30
2.8. Assumptions 30
3. Market Overview 31
3.1. Drivers 33
3.1.1. Increase In Chronic And Infectious Diseases 33
3.1.2. Advancement Of Technology 34
3.2. Restraints 35
3.2.1. Rising Cost Of Poct Tests 35
3.2.2. Low Reimbursement Scenario 35
3.3. Opportunities 36
3.3.1. Scope For Unmet Medical Needs 36
3.3.2. Emerging Poct Device Market 36
3.4. Threats 37
3.4.1. Lack Of Accuracy And Threats 37
3.4.2. Testing Performed By Non Laboratory Personnel And Lack Of Awareness Among The Users 38
4. Executive Summary 39
5. Premium Insights 42
6. Asia-Pacific Point-Of-Care Testing Market; Regulatory Scenario 45
6.1. Overview 45
6.1.1. Regulatory Procedure; 45
6.2. Cfda 46
6.3. Tga 47
6.4. India (Cdsco) 48
6.5. Japan (Mhlw) 49
7. Asia-Pacific Point-Of-Care Testing Market; Reimbursement Scenario 51
7.1. Overview 51
8. Asia-Pacific Point-Of-Care Testing Market, By Product Type 52
8.1. Overview 53
8.2. Cardiometabolic Monitoring Kits 56
8.2.1. Cardiac Markers 59
8.2.2. Blood Gas Electrolyte Testing Kits 59
8.2.3. Hba1C Testing Kits 60
8.2.4. Lipid Testing Kits 60
8.3. Infectious Disease Testing Kits 61
8.3.1. Influenza Testing Kits 64
8.3.2. Hiv Testing Kits 64
8.3.3. Hepatitis Testing Kits 65
8.3.4. Std Testing Kits 65
8.3.5. Tropical Diseases Testing Kits 66
8.3.6. Healthcare Associated Testing Kits 66
8.3.7. Respiratory Infections Testing Kits 67
8.4. Cholesterol Testing Kits 68
8.4.1. Prothrombin Time Testing Kits 71
8.4.2. Activated Clotting Time Testing Kits 71
8.5. Blood Glucose Testing Kits 72
8.6. Pregnancy And Fertility Testing Kits 74
8.7. Tumor Cancer Markers 76
8.8. Urinalysis Testing Kits 78
8.9. Hematology Testing Kits 80
8.10. Drugs Of Abuse Testing Kits 82
8.11. Fecal Occult Testing Kits 84
8.12. Rapid Coagulation Testing Kits 85
9. Asia-Pacific Point-Of-Care Testing Market, By Distribution Channel 87
9.1. Overview 88
9.1.1. Direct Tender 90
9.1.2. Retail Pharmacy 92
10. Asia-Pacific Point-Of-Care Testing Market, By End User 94
10.1. Overview 95
10.2. Asia-Pacific Poct Market; Hospitals 98
10.3. Asia-Pacific Poct Market; Clinics 101
10.4. Asia-Pacific Poct Market; Ambulatory Care 103
10.5. Asia-Pacific Poct Market; Home Healthcare 105
10.6. Asia-Pacific Poct Market; Research Laboratories 107
11. Asia-Pacific Point-Of-Care Testing Market, By Prescription Mode 109
11.1. Overview 110
11.2. Asia-Pacific Poct Market; Prescription Based Testing Kits 112
11.3. Asia-Pacific Poct Market; Over The Counter Based Testing Kits 115
12. Asia-Pacific Point-Of-Care Testing Market, By Geography 118
12.1. Asia-Pacific Point-Of-Care Testing Market 119
12.1.1. Japan Point-Of-Care Testing Market 131
12.1.2. China Point-Of-Care Testing Market 135
12.1.3. South Korea Point-Of-Care Testing Market 139
12.1.4. India Point-Of-Care Testing Market 143
12.1.5. Australia Point-Of-Care Testing Market 147
12.1.6. Singapore Point-Of-Care Testing Market 151
12.1.7. Thailand Point-Of-Care Testing Market 155
12.1.8. Malaysia Point-Of-Care Testing Market 159
12.1.9. Indonesia Point-Of-Care Testing Market 163
12.1.10. Philippines Point-Of-Care Testing Market 167
12.1.11. Rest Of Asia-Pacific Point-Of-Care Testing Market 171
12.2. Company Share Analysis; Asia-Pacific 173
13. Company Profiles 174
13.1. Johnson And Johnson Services, Inc. 174
13.1.1. Company Overview 174
13.1.2. Revenue Analysis 175
13.1.3. Product Portfolio 175
13.1.4. Recent Developments 175
13.2. Becton, Dickinson And Company 176
13.2.1. Company Overview 176
13.2.2. Revenue Analysis 177
13.2.3. Product Portfolio 177
13.2.4. Recent Developments 178
13.3. Medtronic 179
13.3.1. Company Overview 179
13.3.2. Revenue Analysis 180
13.3.3. Product Portfolio 180
13.3.4. Recent Developments 181
13.4. F. Hoffmann-La Roche Ltd 182
13.4.1. Company Overview 182
13.4.2. Revenue Analysis 182
13.4.3. Product Portfolio 183
13.4.4. Recent Developments 184
13.5. Siemens Ag 185
13.5.1. Company Overview 185
13.5.2. Revenue Analysis 185
13.5.3. Product Portfolio 186
13.5.4. Recent Developments 187
13.6. Abbott 188
13.6.1. Company Overview 188
13.6.2. Revenue Analysis 189
13.6.3. Product Portfolio 189
13.6.4. Product Pipeline 190
13.6.5. Recent Developments 191
13.7. Danaher 192
13.7.1. Company Overview 192
13.7.2. Revenue Analysis 193
13.7.3. Product Portfolio 194
13.7.4. Recent Developments 194
13.8. Werfenlife 195
13.8.1. Company Overview 195
13.8.2. Revenue Analysis 196
13.8.3. Product Portfolio 197
13.8.4. Recent Developments 197
?
13.9. Henry Schein, Inc. 198
13.9.1. Company Overview 198
13.9.2. Revenue Analysis 199
13.9.3. Product Portfolio 199
13.9.4. Recent Developments 201
13.10. Opti Medical (Subsidiary Of Idexx Laboratories, Inc) 202
13.10.1. Company Overview 202
13.10.2. Revenue Analysis 203
13.10.3. Product Portfolio 203
13.10.4. Recent Developments 204
13.11. Sienco, Inc. 205
13.11.1. Company Overview 205
13.11.2. Revenue Analysis 205
13.11.3. Product Portfolio 206
13.11.4. Recent Developments 206
13.12. Acon Laboratories, Inc. 207
13.12.1. Company Overview 207
13.12.2. Revenue Analysis 207
13.12.3. Product Portfolio 208
13.12.4. Recent Developments 209
13.13. Ativa Medical Corporation 210
13.13.1. Company Overview 210
13.13.2. Revenue Analysis 210
13.13.3. Product Portfolio 211
13.13.4. Recent Developments 211
13.14. Abaxis 212
13.14.1. Company Overview 212
13.14.2. Revenue Analysis 213
13.14.3. Product Portfolio 213
13.14.4. Recent Developments 214
13.15. Arkray, Inc 215
13.15.1. Company Overview 215
13.15.2. Revenue Analysis 215
13.15.3. Product Portfolio 216
13.15.4. Recent Developments 216
13.16. Aerscher Diagnostics, Llc 217
13.16.1. Company Overview 217
13.16.2. Revenue Analysis 217
13.16.3. Product Portfolio 218
13.16.4. Recent Developments 218
13.17. Artron Laboratories, Inc. 219
13.17.1. Company Overview 219
13.17.2. Revenue Analysis 219
13.17.3. Product Portfolio 220
13.17.4. Recent Developments 222
13.18. Biomerieux Sa 223
13.18.1. Company Overview 223
13.18.2. Revenue Analysis 224
13.18.3. Product Portfolio 225
13.18.4. Recent Developments 225
13.19. Entopsis 226
13.19.1. Company Overview 226
13.19.2. Revenue Analysis 226
13.19.3. Product Portfolio 227
13.19.4. Recent Developments 227
?
13.20. Lifesign, Llc. 228
13.20.1. Company Overview 228
13.20.2. Revenue Analysis 228
13.20.3. Product Portfolio 229
13.20.4. Recent Developments 229
14. Related Reports 230